J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug
Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies. The post J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug appeared first on Investor's Business Daily.
Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.
The post J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
